Integrated Diagnostics : Presentation for 1Q2022 results
June 08, 2022 at 04:02 am EDT
Share
IDH Results Presentation
June 2022
Contents:
IDH At a Glance
Q1 2022 Results Overview
Key Investment Highlights
Our Market
Our Business Model
Financial Position and Performance
Growth Strategies
Governance
Who We Are
Integrated Diagnostics Holding is a leading, fully-integrated provider of high-quality medical
diagnostic services with a footprint spanning Egypt, Jordan, Sudan and Nigeria
Our Services
Our Brands
Accreditations
Immunology Radiology Hematology
Endocrinology
Clinical
Molecular
Chemistry
Biology
Cytogenetics Histopathology Microbiology
+ 40 years
7 key brands
520
33.7 MN
Hena Holdings
Track record
With strong awareness
Branch labs as at 31 Mar. 2022
FY21 Tests
21%
EGP 5.0BN
Shareholding 54%
Ltd
+2,000
4
10.3 MN
Actis Idn B.V.
Structure
Free Float
Diagnostic tests
Country footprint (Egypt,
FY21 Patients
FY21 Net Sales
Jordan, Sudan & Nigeria)
offered
26%
3 INTEGRATED DIAGNOSTICS HOLDINGS
Our Geography
IDH currently operates the largest branch network amongst private providers in Egypt and boasts
an established presence in three key markets in the Middle East and Africa
Jordan
Egypt
1979
472
#1
79%
First began
Branches (49% in
Market Ranking1
Share of
(#1 in Corporate
consolidated net
operations
Cairo Region)
Insurance Sector)
sales in Q1 2022
8.5 mn
29.7 mn
Patients served
Tests performed
in 2021
in 2021
Nigeria
Egypt
Jordan
2011
21
#1
19%
1.6 mn
1.6 mn
Acquisition of
Share of
Patients served
Tests performed
Branches
Market Ranking1
consolidated net
Biolab
in 2021
in 2021
sales in Q1 2022
Sudan
2018
10
1.3%
153k
281k
Nigeria
Acquisition of
Branches
Share of consolidated
Patients served
Tests performed
Echo Lab
net sales in Q1 2022
in 2021
in 2021
2011
17
#1
0.5%
70k
182k
Sudan
First began
Share of
Patients served
Tests performed
Branches
Market Ranking1
consolidated net
operations
in 2021
in 2021
sales in Q1 2022
1 Market ranking amongst private players in each respective country.
4 INTEGRATED DIAGNOSTICS HOLDINGS
Our Patients
IDH serves two principal types of patients: contract and walk-in
Around 70% of total revenue generated across the two segments is paid in cash
Contract Patients
Walk-In Patients
IDH's contract clients include institutions who enter into one-year renewable contracts at agreed rates per-testand on a per-clientbasis. Around 40% of the revenue generated by the segment is paid in cash. IDH's corporate clients roster currently features institutions such as:
Unions
IDH's walk-in clients, also referred to as "self-payers",pay out of pocket for diagnostic tests and other services.
Syndicates
Private and public insurance companies
Banks and corporations
Public institutions
Contribution to IDH Net Sales (Q1 2022)
42% EGP
1,117
mn 58%
Patient Split by Segment (Q1 2022)
37%
2.6 mn
patients
63%
Contract Revenues
Walk-in Revenues
Contract Patients
Walk-in Patients
5 INTEGRATED DIAGNOSTICS HOLDINGS
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
IDH - Integrated Diagnostics Holdings plc published this content on 08 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2022 08:01:01 UTC.
Integrated Diagnostics Holdings PLC is a consumer healthcare company. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, histopathology, genetics, radiology and others. The Companyâs brands include Al Borg Scan, Al Mokhtabar, Ultralab, Biolab, Echo-Lab and others. It operates in approximately 552 branches. It offers more than 3,000 diagnostics tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy and substance abuse. Through Al Borg Scan, it offers a full range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), electromyography (EMG), electrocardiogram (ECG), electroencephalogram (EEG), ultrasound, x-ray, mammograms and cath lab facilities.
INTEGRATED DIAGNOSTICS HOLDINGS PLC 
